Category Archives: Health policy

Uncertain outlook for pediatric dental benefits in a post-ACA world

Mary Otto

About Mary Otto

Mary Otto, a Washington, D.C.-based freelancer, is AHCJ's topic leader on oral health, curating related material at healthjournalism.org. She welcomes questions and suggestions on oral health resources at mary@healthjournalism.org.

Oral health advocates are closely watching Capitol Hill.

Many are worried about the future of children’s dental benefits under proposed Republican plans to repeal or replace the Patient Protection and Affordable Care Act (ACA). Continue reading

Tuning in to health care with the podcast boom

Joanne Kenen

About Joanne Kenen

Joanne Kenen, (@JoanneKenen) the health editor at Politico, is AHCJ’s topic leader on health reform and curates related material at healthjournalism.org. She welcomes questions and suggestions on health reform resources and tip sheets at joanne@healthjournalism.org.

Photo: Matthew Keefe via Flickr

Photo: Matthew Keefe via Flickr

Podcasts are all the rage, so we’ve been collecting some health policy-related ones for you. Some of these regularly tackle health policy, some dip into it once in a while (but smartly) and others are geared more toward science and medicine.

Some of you who contributed suggestions noted that a few popular general podcasts (such as On Media and Fresh Air) aren’t health-focused but sometimes have good episodes, respectively, on media coverage and interviews with authors of health books. Continue reading

Surgeon general responds to journalists on range of public health issues #AHCJ16

Pia Christensen

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

Following his prepared remarks at Health Journalism 2016, United States Surgeon General Vivek H. Murthy, M.D., M.B.A., (@Surgeon_General) answered some questions from journalists about opioids, alcohol, marijuana, mental health, gun violence, the relationship between science and public policy, and more.

Watch surgeon general’s speech at Health Journalism 2016 #AHCJ16

Pia Christensen

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

United States Surgeon General Vivek H. Murthy, M.D., M.B.A., (@Surgeon_General) spoke to attendees of Health Journalism 2016 and discussed how his administration will address the overuse of opioids in the United States.

A follow-up blog post will feature Murthy answering journalists’ questions after his prepared talk.

Chicago panel explores the world of drug pricing

Carla K. Johnson

About Carla K. Johnson

Carla K. Johnson (@CarlaKJohnson) is a medical writer at The Associated Press and has covered health and medicine since 2001. A former member of AHCJ's board of directors, she leads the Chicago AHCJ chapter.

Photo: Carla K. JohnsonCraig Garthwaite, assistant professor, Northwestern University's Kellogg School of Management (left); Roy Guharoy, Pharm.D. vice president and chief pharmacy officer for the Resource Group at Ascension (middle); and independent journalist and AHCJ member Duncan Moore (right) spoke at the Chicago chapter event “Drug Pricing: Covering the Controversy” at Columbia College in Chicago on Feb. 23.

Photo: Carla K. JohnsonCraig Garthwaite, assistant professor, Northwestern University’s Kellogg School of Management (left); Roy Guharoy, Pharm.D. vice president and chief pharmacy officer for the Resource Group at Ascension (middle); and independent journalist and AHCJ member Duncan Moore (right) spoke at the Chicago chapter event “Drug Pricing: Covering the Controversy” at Columbia College in Chicago on Feb. 23.

A blockbuster hepatitis C drug costs $84,000, straining state budgets. Martin Shkreli acquires the rights to a generic and raises its price 5,000 percent. Presidential candidates react to the public outcry, claiming they know what to do about the drug prices.

What does it all mean? Until recently, “there’s been an equilibrium in the public mind between a free market regimen of the market setting prices and what the public and payers are willing to pay,” said independent journalist Duncan Moore,  “but there are indications this informal tradeoff has begun to swing out of control.” Continue reading